RedHill Biopharma Ltd. announced the appointment of Mr. Rick D. Scruggs to its Board of Directors, effective January 1, 2016. With over 25 years of experience in the pharmaceutical industry, Mr. Scruggs brings extensive knowledge in commercial operations and business development. He most recently served as Executive Vice President of Business Development at Salix Pharmaceuticals Ltd. (Salix), up to its acquisition by Valeant Pharmaceuticals International earlier this year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4581 USD | -0.04% | -1.02% | -68.62% |
06/05 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
06/05 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
1st Jan change | Capi. | |
---|---|---|
-68.62% | 1.46Cr | |
-2.29% | 8.99TCr | |
-3.95% | 3.76TCr | |
+63.05% | 2.65TCr | |
-22.14% | 1.43TCr | |
-7.96% | 1.3TCr | |
-9.33% | 1.19TCr | |
-46.33% | 1.08TCr | |
+5.77% | 911.12Cr | |
-17.66% | 732.39Cr |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- RedHill Biopharma Announces Appointment of Rick D. Scruggs to Board of Directors, Effective January 1, 2016